DKK2 and Alzheimer disease: This was accompanied by unchanged relative contributions of DKK2+ microglia across control (38.3 ± 9.7%), pathologic aging (38.3 ± 3.8%), and AD groups (41.6 ± 12.5%; Extended Data Fig. 6-1A; one-way ANOVA, p = 0.8650y).